We are pleased to present the March 2021 issue of Dechert LLP’s UK Life Sciences and Healthcare Newsletter.
This month's Newsletter provides an insight into current developments, analysis and news, including:
- An update on Future Fund: Breakthrough, a further fund for development launched by the British Business Bank.
- An update on various issues that should be considered when UK-based employees are granted incentives under stock-based plans operated by U.S. companies.
- A guest contributor feature from Charles Swingland, chairman of Vaxerna Limited: "COVID has Brought Unexpected New Approaches to Autoimmune and Allergic Diseases"
Related Professionals
